首页> 外文OA文献 >SAT0158 Efficacy of switching from etanercept to adalimumab in rheumatoid arthritis and psoriatic arthritis patients who experienced a first-line biologic therapy failure: the fearless study

【2h】

SAT0158 Efficacy of switching from etanercept to adalimumab in rheumatoid arthritis and psoriatic arthritis patients who experienced a first-line biologic therapy failure: the fearless study

机译：SAT0158 SAT0158从依赖替埃替斯科对类木盆关节炎和经历一线生物治疗衰竭的患者的疗效切换到阿达木偶单抗：无所畏惧的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
EG Favalli; A Becciolini; A Carletto; F Conti; G Amato; E Fusaro; L Quartuccio; A Lo Monaco; M Benucci; F Salaffi; A Semeraro; M Biggioggero; S Parisi; F Ceccarelli; I Piazza; R Foti;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: Results from the US CORRONA registry [J] . GreenbergJ.D., ReedG., DecktorD., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2012,第7期

机译：阿达木单抗，依那西普和英夫利昔单抗在生物学上和转换后的类风湿关节炎患者中的比较有效性研究：美国CORRONA注册中心的结果
2. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis [J] . Cantini Fabrizio, Niccoli Laura, Nannini Carlotta, Seminars in Arthritis and Rheumatism . 2016,第5期

机译：针对类风湿性关节炎，脊椎关节炎和银屑病关节炎的患者进行量身定制的一线生物治疗
3. Retention rates of adalimumab, etanercept and infliximab as first-line biotherapy agent for rheumatoid arthritis patients in daily practice - Auvergne experience [J] . Soubrier Martin, Pereira Bruno, Frayssac Thomas, International journal of rheumatic diseases . 2018,第11期

机译：Adalimalab，依赖替替替替替替昔单抗的保留率作为日常生活中类风湿性关节炎患者的一线生物治疗剂 - Auvergne经验
4. Psoriatic arthritis Clinical improvement and correlation with hormone axes in etanercept-treated patients [C] . Fabiola Atzeni, Rainer H. Straub, Maurizio Cutolo, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：依托西普治疗患者患者临床改善及与激素轴相关性
5. “Don’t Rock the Boat”: A Qualitative Narrative Study Exploring Rheumatoid Arthritis Patients’ Experience of Illness and Biologics [D] . Rachich, Meagan . 2020

机译：“不要摇滚船”：探索类风湿性关节炎患者的疾病和生物学经验的定性叙事研究
6. Long-term efficacy safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre randomised double-blind parallel-group study [O] . Min-Chan Park, Hiroaki Matsuno, Jinseok Kim, 2019

机译：使用依那西普生物仿制药（LBEC0101）或从参考依那西普转为LBEC0101的类风湿关节炎患者的长期疗效安全性和免疫原性：III期多中心随机双盲平行分组研究的开放标签扩展
7. POS0592 BIOSIMILAR INFLIXIMAB THERAPY IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A LONG-TERM FOLLOW-UP STUDY ON INFLIXIMAB-NAÏVE PATIENTS AND PATIENTS SWITCHED FROM THE ORIGINATOR TO THE BIOSIMILAR CT-P13 [O] . B. Fautrel, M. Assing, N. Mammar, 2021

机译：POS0592 BioSimilar Infliximab疗法在类风湿性关节炎，强直性脊柱炎和银屑病关节炎：对富生素-Naïve患者的长期随访研究和从发起者转换为生物邮件CT-P13的患者
8. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults [R] . Donahue, K. E., Gartlehner, G., Jonas, D. E., 2007

机译：药物治疗对成人类风湿性关节炎和银屑病关节炎的疗效比较

SAT0158 Efficacy of switching from etanercept to adalimumab in rheumatoid arthritis and psoriatic arthritis patients who experienced a first-line biologic therapy failure: the fearless study

著录项

相似文献

相关主题

期刊订阅